The bispecific antibody market is experiencing rapid growth, primarily driven by the increasing prevalence of complex chronic diseases, such as cance ...

A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...

References Bailey, S. R. et al. IFN-γ-resistant CD28 CAR T cells demonstrate increased survival, efficacy, and durability in multiple murine tumor models. Sci.Transl Med. 17, eadp8166 (2025).

This how to guide explores integrated strategies and technologies that support consistent, efficient and scalable cell therapy manufacturing.

Furthermore, the efficacy of our prognostic signature was validated through clinicopathological analyses conducted at our institution.In conclusion, the B7/CD28 family plays an active role in the ...